Nanocarriers for Anticancer Drugs - New Trends in Nanomedicine

被引:78
|
作者
Drbohlavova, Jana [1 ,2 ]
Chomoucka, Jana [1 ,2 ]
Adam, Vojtech [2 ]
Ryvolova, Marketa [2 ]
Eckschlager, Tomas [3 ,4 ]
Hubalek, Jaromir [1 ,2 ]
Kizek, Rene [2 ]
机构
[1] Brno Univ Technol, Fac Elect Engn & Commun, Dept Microelect, CZ-61600 Brno, Czech Republic
[2] Mendel Univ Brno, Fac Agron, Dept Chem & Biochem, CZ-61300 Brno, Czech Republic
[3] Charles Univ Prague, Fac Med 2, Dept Paediat Haematol & Oncol, CZ-15006 Prague 5, Czech Republic
[4] Motol Univ Hosp, CZ-15006 Prague 5, Czech Republic
关键词
Nanotechnologies; nanoparticles; gene therapy; anticancer drugs; drug carriers; cancer; cytostatic; targeted therapy; SOLID LIPID NANOPARTICLES; MESOPOROUS SILICA NANOPARTICLES; MOLECULARLY IMPRINTED POLYMERS; PRODRUG THERAPY ADEPT; QUANTUM DOTS; GOLD NANOPARTICLES; CANCER-CELLS; IN-VIVO; TARGETED DELIVERY; CARBON NANOTUBES;
D O I
10.2174/1389200211314050005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review provides a brief overview of the variety of carriers employed for targeted drug delivery used in cancer therapy and summarizes advantages and disadvantages of each approach. Particularly, the attention was paid to polymeric nanocarriers, liposomes, micelles, polyethylene glycol, poly(lactic-co-glycolic acid), dendrimers, gold and magnetic nanoparticles, quantum dots, silica nanoparticles, and carbon nanotubes. Further, this paper briefly focuses on several anticancer agents (paclitaxel, docetaxel, camptothecin, doxorubicin, daunorubicin, cisplatin, curcumin, and geldanamycin) and on the influence of their combination with nanoparticulate transporters to their properties such as cytotoxicity, short life time and/or solubility.
引用
收藏
页码:547 / 564
页数:18
相关论文
共 50 条
  • [1] Buckysomes: New Nanocarriers for Anticancer Drugs
    Danila, Delia
    Golunski, Eva
    Partha, Ranga
    McManus, Madonna
    Little, Tina
    Conyers, Jodie
    [J]. JOURNAL OF PHARMACEUTICS, 2013, 2013
  • [2] Nanocarriers for delivery of platinum anticancer drugs
    Oberoi, Hardeep S.
    Nukolova, Natalia V.
    Kabanov, Alexander V.
    Bronich, Tatiana K.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (13-14) : 1667 - 1685
  • [3] Nanocarriers for anticancer drugs: Challenges and perspectives
    Alqosaibi, Amany I.
    [J]. SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2022, 29 (06)
  • [4] Advances in Nanocarriers for Anticancer Drugs Delivery
    Ali, Imran
    Lone, Mohammad Nadeem
    Suhail, Mohammad
    Mukhtar, Sofi Danish
    Asnin, Leonid
    [J]. CURRENT MEDICINAL CHEMISTRY, 2016, 23 (20) : 2159 - 2187
  • [5] Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs
    Sabit, Hussein
    Abdel-Hakeem, Mohamed
    Shoala, Tahsin
    Abdel-Ghany, Shaimaa
    Abdel-Latif, Mokhtar Mamdouh
    Almulhim, Jawaher
    Mansy, Mohamed
    [J]. PHARMACEUTICS, 2022, 14 (08)
  • [6] Obstacles impeding the development of nanocarriers for anticancer drugs
    Liu, Lingshan
    Dou, Hongjing
    [J]. NANOMEDICINE, 2021, 16 (17) : 1447 - 1450
  • [7] Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers
    Kumar, Girish
    Virmani, Tarun
    Sharma, Ashwani
    Pathak, Kamla
    [J]. PHARMACEUTICS, 2023, 15 (03)
  • [8] Nanocarriers for Anticancer Drug Targeting Recent Trends and Challenges
    Dahiya, Sunita
    Dahiya, Rajiv
    Hernandez, Eliud
    [J]. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2021, 38 (06): : 49 - 103
  • [9] Recent trends in the design of anticancer polymer prodrug nanocarriers
    Delplace, Vianney
    Couvreur, Patrick
    Nicolas, Julien
    [J]. POLYMER CHEMISTRY, 2014, 5 (05) : 1529 - 1544